原发性硬化性胆管炎患者的随访磁共振成像/三维磁共振胰胆管成像:专家解读亦具挑战性
国际原发性硬化性胆管炎研究组对16例真实病例(含临床生化信息及T2加权肝脏MRI/三维MRCP)开展在线问卷调查,44名成员/协作成员完成。结果显示,专家对随访MRI的解读差异显著,其中对是否行后续ERCP的同意度最低(Κ=0.12,95%CI 0.11-0.14);总胆红素升高是对疑似优势狭窄、胆管癌或ERCP推荐影响最强的变量。
要点
- 44名国际原发性硬化性胆管炎研究组成员/协作成员完成16例病例的在线问卷。
- 对是否行后续ERCP的同意度最低,Κ=0.12(95%CI 0.11-0.14)。
- 总胆红素升高是对疑似优势狭窄、胆管癌或ERCP推荐影响最强的变量。
核心结论
- 在原发性硬化性胆管炎中,即使专家间对随访MRI/三维MRCP的解读也显著不同,且似乎主要受胆红素水平影响。
- 亟需公认的基于MRI的原发性硬化性胆管炎相关并发症定义。
研究设计与样本
- 国际原发性硬化性胆管炎研究组开展在线问卷调查,纳入16例真实原发性硬化性胆管炎病例,提供临床和生化信息以及T2加权肝脏MRI/三维MRCP。
- 采用多项选择问卷评估图像解读及后续推荐,计算评分者间信度(Fleiss kappa),并用广义线性混合效应模型分析可能影响磁共振图像解读的因素。
主要发现
- 44名国际原发性硬化性胆管炎研究组成员/协作成员完成调查,照护原发性硬化性胆管炎患者的中位经验为14年。
- 参与者对MRI的解读显著不同。
- 对是否行后续ERCP的同意度最低(Κ=0.12,95%CI 0.11-0.14)。
- 总胆红素升高是对疑似优势狭窄、胆管癌或ERCP推荐影响最强的变量。
- 肝硬化并未阻止参与者推荐ERCP。
关键数值与推荐
- 对是否行后续ERCP的同意度最低:Κ=0.12(95%CI 0.11-0.14)。
- 照护原发性硬化性胆管炎患者的中位经验为14年。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In patients with primary sclerosing cholangitis follow-up magnetic resonance imaging (MRI) with magnetic resonance cholangiopancreatography (MRCP) is performed by many centres, particularly for the early detection of biliary malignancies and strictures. Clinically meaningful MRI-based definitions of primary sclerosing cholangitis related complications are, however, lacking. AIM: To investigate how primary sclerosing cholangitis experts interpret follow-up MRI/MRCP with a focus on conclusions that may impact clinical decision-making in primary sclerosing cholangitis. METHODS: Within the International Primary Sclerosing Cholangitis Study Group, an online survey on 16 real-life primary sclerosing cholangitis cases including clinical and biochemical information as well as a T2-weighted liver MRI/3D-MRCP was conducted. The interpretation of images and subsequent recommendations were assessed using a multiple-choice questionnaire. An inter-rater reliability calculation (Fleiss' kappa) was performed and factors potentially affecting the interpretation of magnetic resonance images were analysed using generalised linear mixed-effect models. RESULTS: Forty-four members/associates of the International Primary Sclerosing Cholangitis Study Group (median experience in the care of primary sclerosing cholangitis patients: 14 years) completed the survey. The MRI interpretation significantly varied among the participants. The lowest agreement was found with respect to the indication to perform subsequent endoscopic retrograde cholangiopancreatography (ERCP; Κ = 0.12, 95%CI 0.11-0.14). Elevated total bilirubin was the variable with the strongest effect on the rate of suspected dominant strictures, cholangiocarcinoma or ERCP recommendations. Liver cirrhosis did not prevent participants from recommending ERCP. Overall, the survey participants' recommendations contrasted the real-life management and outcome. CONCLUSIONS: In primary sclerosing cholangitis, the interpretation of follow-up MRI/3D-MRCP significantly varies even among experts and seems to be primarily affected by bilirubin levels. Generally accepted MRI-based definitions of primary sclerosing cholangitis-related complications are urgently needed.
引用
- Zenouzi R, Liwinski T, Yamamura J, et al. Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret. Aliment Pharmacol Ther. 2018. PMID: 29741240. doi:10.1111/apt.14797
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。